Literature DB >> 8703114

Cloning and comparative mapping of a gene from the commonly deleted region of DiGeorge and Velocardiofacial syndromes conserved in C. elegans.

P Rizzu1, E A Lindsay, C Taylor, H O'Donnell, A Levy, P Scambler, A Baldini.   

Abstract

We have identified and cloned a gene, ES2, encoding a putative 476 amino acid protein with a predicted Mr of 52,568. The gene is localized within the DiGeorge/Velocardiofacial syndrome locus on 22q11.2 and is deleted in all the patients in which a deletion within 22q11 could be demonstrated, with the exception of one patient. ES2 is expressed in all the tissues studied. Sequence comparison showed identity with five ESTs and at the amino acid level the sequence was highly similar to, and collinear with, a hypothetical C. elegans protein of unknown function. Mutation analysis was performed in 16 patients without deletion, but no mutation has been found. The cDNA sequence is conserved in mouse and is localized on MMU16B1-B3, known to contain a syntenic group in common with HSA 22q11.2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8703114     DOI: 10.1007/s003359900197

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  21 in total

1.  DiGeorge syndrome and 22q11 rearrangements.

Authors:  S Augusseau; S Jouk; P Jalbert; M Prieur
Journal:  Hum Genet       Date:  1986-10       Impact factor: 4.132

2.  An expression-independent catalog of genes from human chromosome 22.

Authors:  J A Trofatter; K R Long; J R Murrell; C J Stotler; J F Gusella; A J Buckler
Journal:  Genome Res       Date:  1995-10       Impact factor: 9.043

3.  Mapping human YAC clones by fluorescence in situ hybridization using Alu-PCR from single yeast colonies.

Authors:  A Baldini; E A Lindsay
Journal:  Methods Mol Biol       Date:  1994

4.  Molecular cytogenetic characterization of the DiGeorge syndrome region using fluorescence in situ hybridization.

Authors:  E A Lindsay; S Halford; R Wadey; P J Scambler; A Baldini
Journal:  Genomics       Date:  1993-08       Impact factor: 5.736

5.  Velocardiofacial syndrome in a mother and daughter: variability of the clinical phenotype.

Authors:  S E Holder; R M Winter; S Kamath; P J Scambler
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

6.  Clinical and molecular study of DiGeorge sequence.

Authors:  A Levy-Mozziconacci; F Wernert; P Scambler; F Rouault; D Metras; B Kreitman; D Depetris; M G Mattei; N Philip
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

7.  Isolation of a gene encoding an integral membrane protein from the vicinity of a balanced translocation breakpoint associated with DiGeorge syndrome.

Authors:  R Wadey; S Daw; C Taylor; U Atif; S Kamath; S Halford; H O'Donnell; D Wilson; J Goodship; J Burn
Journal:  Hum Mol Genet       Date:  1995-06       Impact factor: 6.150

8.  Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions.

Authors:  E A Lindsay; R Goldberg; V Jurecic; B Morrow; C Carlson; R S Kucherlapati; R J Shprintzen; A Baldini
Journal:  Am J Med Genet       Date:  1995-07-03

9.  Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene.

Authors:  M L Budarf; J Collins; W Gong; B Roe; Z Wang; L C Bailey; B Sellinger; D Michaud; D A Driscoll; B S Emanuel
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

10.  Cloning of a balanced translocation breakpoint in the DiGeorge syndrome critical region and isolation of a novel potential adhesion receptor gene in its vicinity.

Authors:  S Demczuk; R Aledo; J Zucman; O Delattre; C Desmaze; L Dauphinot; P Jalbert; G A Rouleau; G Thomas; A Aurias
Journal:  Hum Mol Genet       Date:  1995-04       Impact factor: 6.150

View more
  9 in total

1.  DGCR14 induces Il17a gene expression through the RORγ/BAZ1B/RSKS2 complex.

Authors:  Ichiro Takada
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

2.  Transmission disequilibrium test provides evidence of association between promoter polymorphisms in 22q11 gene DGCR14 and schizophrenia.

Authors:  H Wang; S Duan; J Du; X Li; Y Xu; Z Zhang; Y Wang; G Huang; G Feng; L He
Journal:  J Neural Transm (Vienna)       Date:  2006-01-25       Impact factor: 3.575

3.  Cloning and mapping of murine Dgcr2 and its homology to the Sez-12 seizure-related protein.

Authors:  C Taylor; R Wadey; H O'Donnell; C Roberts; M G Mattei; W L Kimber; A Wynshaw-Boris; P J Scambler
Journal:  Mamm Genome       Date:  1997-05       Impact factor: 2.957

4.  The DiGeorge syndrome minimal critical region contains a goosecoid-like (GSCL) homeobox gene that is expressed early in human development.

Authors:  S Gottlieb; B S Emanuel; D A Driscoll; B Sellinger; Z Wang; B Roe; M L Budarf
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

5.  Comparative mapping of the DiGeorge syndrome region in mouse shows inconsistent gene order and differential degree of gene conservation.

Authors:  A Botta; E A Lindsay; V Jurecic; A Baldini
Journal:  Mamm Genome       Date:  1997-12       Impact factor: 2.957

6.  Direct selection of conserved cDNAs from the DiGeorge critical region: isolation of a novel CDC45-like gene.

Authors:  J M McKie; R B Wadey; H F Sutherland; C L Taylor; P J Scambler
Journal:  Genome Res       Date:  1998-08       Impact factor: 9.043

7.  Systematic analyses of rpm-1 suppressors reveal roles for ESS-2 in mRNA splicing in Caenorhabditis elegans.

Authors:  Kentaro Noma; Alexandr Goncharov; Yishi Jin
Journal:  Genetics       Date:  2014-09-05       Impact factor: 4.562

Review 8.  In the line-up: deleted genes associated with DiGeorge/22q11.2 deletion syndrome: are they all suspects?

Authors:  Zahra Motahari; Sally Ann Moody; Thomas Michael Maynard; Anthony-Samuel LaMantia
Journal:  J Neurodev Disord       Date:  2019-06-07       Impact factor: 4.025

Review 9.  The PHR proteins: intracellular signaling hubs in neuronal development and axon degeneration.

Authors:  Brock Grill; Rodney K Murphey; Melissa A Borgen
Journal:  Neural Dev       Date:  2016-03-23       Impact factor: 3.842

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.